{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:28:25Z","timestamp":1788409705282,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/jjco\/hyy038","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T16:10:35Z","timestamp":1521216635000},"page":"542-547","source":"Crossref","is-referenced-by-count":9,"title":["A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients"],"prefix":"10.1093","volume":"48","author":[{"given":"Satoshi","family":"Inoue","sequence":"first","affiliation":[{"name":"Clinical Development Department, R&D Division, Daiichi Sankyo Co., Ltd, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Shimane University Faculty of Medicine, Shimane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Tsuneto","sequence":"additional","affiliation":[{"name":"Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Aruga","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Teikyo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Clinical Development Department, R&D Division, Daiichi Sankyo Co., Ltd, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutoshi","family":"Uemori","sequence":"additional","affiliation":[{"name":"Biostatistics & Data Management Department, R&D Division, Daiichi Sankyo Co., Ltd, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"key\n\t\t\t\t20180830004352_hyy038C1","volume-title":"Cancer Pain Relief: With a Guide to Opioid Availability","author":"WHO","year":"1996","edition":"2nd edn"},{"key":"key\n\t\t\t\t20180830004352_hyy038C2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(95)00017-M","article-title":"Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study","volume":"63","author":"Zech","year":"1995","journal-title":"Pain"},{"key":"key\n\t\t\t\t20180830004352_hyy038C3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/15360288.2014.941132","article-title":"An examination of global and regional opioid consumption trends 1980\u20132011","volume":"28","author":"Hastie","year":"2014","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"key\n\t\t\t\t20180830004352_hyy038C4","volume-title":"Report of the International Narcotics Control Board for 2013","author":"International Narcotics Control Board","year":"2014"},{"key":"key\n\t\t\t\t20180830004352_hyy038C5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180830004352_hyy038C6","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180830004352_hyy038C7","doi-asserted-by":"crossref","first-page":"vii139","DOI":"10.1093\/annonc\/mds233","article-title":"ESMO Guidelines Working Group: management of cancer pain: ESMO Clinical Practice Guidelines","volume":"23","author":"Ripamonti","year":"2012","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180830004352_hyy038C8","author":"National Comprehensive Cancer Network","year":"2012"},{"key":"key\n\t\t\t\t20180830004352_hyy038C9","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jpainsymman.2005.01.007","article-title":"Hydromorphone","volume":"29","author":"Murray","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"key\n\t\t\t\t20180830004352_hyy038C10","first-page":"582","volume-title":"Bonica\u2019s Management of Pain, 4e","author":"Fitzgibbon","year":"2010"},{"key":"key\n\t\t\t\t20180830004352_hyy038C11","first-page":"601","volume-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"Yaksh","year":"2011","edition":"12 edn"},{"key":"key\n\t\t\t\t20180830004352_hyy038C12","volume-title":"Palliative Care Formulary","author":"Twycross","year":"2014","edition":"5th edn"},{"key":"key\n\t\t\t\t20180830004352_hyy038C13","first-page":"13","volume-title":"Symptom Management in Advanced Cancer","author":"Twycross","year":"2009","edition":"4th edn"},{"key":"key\n\t\t\t\t20180830004352_hyy038C14","first-page":"661","volume-title":"Opioid Therapy in the 21st Century","author":"Fallon","year":"2014","edition":"2nd edn"},{"key":"key\n\t\t\t\t20180830004352_hyy038C15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5055\/jom.2014.0189","article-title":"Opioid titration with sustained-release oxycodone and immediate-release morphine for moderate\/severe cancer pain: a pilot assessment of the CoDem protocol","volume":"10","author":"Samolsky Dekel","year":"2014","journal-title":"J Opioid Manag"},{"key":"key\n\t\t\t\t20180830004352_hyy038C16","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.2147\/DDDT.S92998","article-title":"Efficacy and tolerability of oral oxycodone and oxycodone\/naloxone combination in opioid-na\u00efve cancer patients: a propensity analysis","volume":"9","author":"Lazzari","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"key\n\t\t\t\t20180830004352_hyy038C17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jjco\/hyh104","article-title":"Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-na\u00efve cancer pain patients, starting with 5 mg tablets","volume":"34","author":"Koizumi","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"key\n\t\t\t\t20180830004352_hyy038C18","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1185\/03007995.2013.831816","article-title":"Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain","volume":"29","author":"Imanaka","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20180830004352_hyy038C19","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1185\/03007995.2012.739151","article-title":"Tapentadol in cancer pain management: a prospective open-label study","volume":"28","author":"Mercadante","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20180830004352_hyy038C20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1089\/jpm.2011.0296","article-title":"Strategic pain management: the identification and development of the IAHPC opioid essential prescription package","volume":"15","author":"Vignaroli","year":"2012","journal-title":"J Palliat Med"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/48\/6\/542\/25536186\/hyy038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T21:21:14Z","timestamp":1570915274000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/48\/6\/542\/4969217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,4,12]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyy038","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,4,12]]}}}